Upgrade to SI Premium - Free Trial

Unusual 11 Mid-Day Movers 11/14: (CRBP) (DRYS) (HAR) Higher; (DVAX) (RSO) (HEAR) Lower

November 14, 2016 1:09 PM
Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) 65.9% HIGHER; announced positive topline results from its Phase 2 study evaluating Resunab ("JBT-101") ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles